CA2481664A1 - Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes - Google Patents

Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes Download PDF

Info

Publication number
CA2481664A1
CA2481664A1 CA002481664A CA2481664A CA2481664A1 CA 2481664 A1 CA2481664 A1 CA 2481664A1 CA 002481664 A CA002481664 A CA 002481664A CA 2481664 A CA2481664 A CA 2481664A CA 2481664 A1 CA2481664 A1 CA 2481664A1
Authority
CA
Canada
Prior art keywords
tamoxifen
appd
estrogen
breast cancer
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002481664A
Other languages
English (en)
Inventor
William Jia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002481664A priority Critical patent/CA2481664A1/fr
Publication of CA2481664A1 publication Critical patent/CA2481664A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002481664A 2004-09-30 2004-09-30 Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes Abandoned CA2481664A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002481664A CA2481664A1 (fr) 2004-09-30 2004-09-30 Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002481664A CA2481664A1 (fr) 2004-09-30 2004-09-30 Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes

Publications (1)

Publication Number Publication Date
CA2481664A1 true CA2481664A1 (fr) 2006-03-30

Family

ID=36121727

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002481664A Abandoned CA2481664A1 (fr) 2004-09-30 2004-09-30 Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes

Country Status (1)

Country Link
CA (1) CA2481664A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2446641A (en) * 2007-02-14 2008-08-20 Tcp Innovations Ltd Triphenylethylene TGF-beta stimulating agents
CN105640968A (zh) * 2016-01-14 2016-06-08 孙妙囡 一种人参皂苷组合物及其应用

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2446641A (en) * 2007-02-14 2008-08-20 Tcp Innovations Ltd Triphenylethylene TGF-beta stimulating agents
GB2446641B (en) * 2007-02-14 2010-10-13 Tcp Innovations Ltd Improved compositions and combinations 2
CN105640968A (zh) * 2016-01-14 2016-06-08 孙妙囡 一种人参皂苷组合物及其应用
CN105640968B (zh) * 2016-01-14 2019-03-19 孙妙囡 一种人参皂苷组合物及其应用

Similar Documents

Publication Publication Date Title
Bedell et al. The pros and cons of plant estrogens for menopause
CN100528167C (zh) 用于治疗癌症的包含雌四醇衍生物的药物组合物
US10201611B2 (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
PT90764B (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
US20080021003A1 (en) Extended step-down estrogen regimen
JP2012529421A (ja) エストロゲン受容体β媒介性疾患の治療のためのニアソールおよびその類似体
KR20210048609A (ko) 선택적 에스트로겐 수용체 조절자와 복합된 성 스테로이드 전구체에 의한 안면 홍조, 혈관 운동성 증상 및 도한증의 치료
AU2005249401A1 (en) Compositions and methods for treatment of premenstrual dysphoric disorder
CA2698739A1 (fr) Extraits oestrogenies de pueraria lobata willd, ohwi de la famille leguminosae et leurs utilisations
TW201002330A (en) Compositions and methods for treating breast cancer
Mukherjee et al. Letrozole: Pharmacology, toxicity and potential therapeutic effects
CZ2007571A3 (cs) Prirozené brassinosteroidy pro použití pri léceníhyperproliferace, lécení proliferativních onemocnení a redukci nepríznivých úcinku steroidních disfunkcí u savcu, farmaceutické prostredky je obsahující a jejich použití
WO2009126923A2 (fr) Extraits œstrogéniques d'anemarrhena asphodéloïdes bge de la famille liliaceae, et leurs utilisations
Dutta et al. Phytoestrogens as novel therapeutic molecules against breast cancer
TW201200135A (en) Compositions and methods for non-toxic delivery of antiprogestins
JP2007512279A (ja) 選択的エストロゲン８β−ビニル−エストラ−１，３，５（１０）−トリエン−３，１７β−ジオール、及び１７β−フルオル−９α−ビニル−エストラ−１，３，５（１０）−トリエン−３，１６α−ジオールによる高血圧性心疾患の予防及び治療
CA2481664A1 (fr) Prevention du cancer du sein a l'aide de nouveaux modulateurs selectifs des recepteurs des oestrogenes
JPWO2004035089A1 (ja) ホルモン依存性癌の治療剤
EP0850647B1 (fr) Application de composés stéroides substitués en ll pour la fabrication de médicaments ayant une activité estrogène dissociée
WO2001032191A2 (fr) Preparations pharmaceutiques phytoestrogeniques
AU2008296078A1 (en) Estrogenic extracts of Rheum palmatum L of the Polygonaceae family and uses thereof
Oettel et al. What is past is prologue: estrogen/progestin replacement tomorrow
Wakeling 11. Steroidal pure antiestrogens
US20210046085A1 (en) Treatment of advanced estrogen receptor positive breast cancer
Sobral New steroidal aromatase inhibitors: biological effects in hormone-dependent breast cancer cell models

Legal Events

Date Code Title Description
FZDE Dead